New Weight-Loss shot shows promise in major trial
NCT ID NCT06728124
First seen Jan 04, 2026 · Last updated Jun 16, 2026 · Updated 24 times
Summary
This phase 3 study tests an investigational injection called GZR18 to help adults with obesity or overweight lose weight. About 630 participants in China will receive either the drug or a placebo, and researchers will measure how much weight they lose over time. The goal is to see if the injection is safe and effective for weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing
Beijing, China
Conditions
Explore the condition pages connected to this study.